The company conducts applied medical research and development, in particular the development of tissue- and cell-based cultures for testing and predicting the therapeutic response of tissues to drugs using newly developed platforms. The company can acquire, manage and transfer patents, trademarks and technical and industrial knowledge. The company can establish branches and subsidiaries in Switzerland and abroad and participate in other companies in Switzerland and abroad, as well as conduct all business that is directly or indirectly related to its purpose. The company can acquire, encumber, sell and manage real estate in Switzerland and abroad. It can also provide financing for its own account or for the account of third parties, as well as provide guarantees and sureties for subsidiaries and third parties.